Pfizer’s Outlook Improves

   June 19, 2003    Comments Off on Pfizer’s Outlook Improves    Posted in: General Biotechnology

Pfizer’s Outlook Improves
Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the drug world. And with its $60 billion Pharmacia merger completed in April, the king just got fatter

  

Comments are closed.

Biotechblog